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Recently, multipotent mesenchymal stem cells (MSCs) have attracted much attention
in the field of regenerative medicine due to their ability to give rise to different cell types,
including chondrocytes. Damaged articular cartilage repair is one of the most challenging
issues for regenerative medicine, due to the intrinsic limited capability of cartilage to heal
because of its avascular nature. While surgical approaches like chondral autografts and
allografts provide symptoms and function improvement only for a short period, MSC
based stimulation therapies, like microfracture surgery or autologous matrix-induced
chondrogenesis demonstrate to be more effective. The use of adult chondrocytes, which
are the main cellular constituent of cartilage, in medical practice, is indeed limited due
to their instability in monolayer culture and difficulty to collect donor tissue (articular
and nasal cartilage). The most recent cartilage engineering approaches combine cells,
biomaterial scaffold and bioactive factors to promote functional tissue replacements.
Many recent evidences demonstrate that scaffolds providing specific microenvironmental
conditions can promote MSCs differentiation toward a functional phenotype. In the
present work, the chondrogenic potential of a new Collagen I based 3D scaffold has been
assessed in vitro, in combination with human adipose-derived MSCs which possess
a higher chondrogenic potential compared to MSCs isolated from other tissues. Our
data indicate that the scaffold was able to promote the early stages of chondrogenic
commitment and that supplementation of specific soluble factors was able to induce the
complete differentiation of MSCs in chondrocytes as demonstrated by the appearance
of cartilage distinctive markers (Sox 9, Aggrecan, Matrilin-1, and Collagen II), as well
Calabrese et al. Chondrogenic Differentiation on Collagen Scaffold
as by the cartilage-specific Alcian Blue staining and by the acquisition of typical cellular
morphology. Such evidences suggest that the investigated scaffold formulation could be
suitable for the production of medical devices that can be beneficial in the field of articular
cartilage engineering, thus improving the efficacy and durability of the current therapeutic
options.
Keywords: mesenchymal stem cells, 3D scaffolds, cartilage repair, chondrogenic differentiation, regenerative
medicine
INTRODUCTION
Chondrogenesis is the biological process leading to the formation
of hyaline, fibrous, and elastic cartilage. Chondrocytes, which
are the unique cellular phenotype in cartilage and differentiate
after the condensation of MSCs (Stott et al., 1999; Ghosh et al.,
2009), can either remain in a quiescent status to form the
articular cartilage, or can proliferate, assuming a hypertrophic
morphology and undergo to the endochondral ossification
process. In such process, the embryonic cartilaginous model of
long bones is gradually replaced by bone tissue, contributing to
bone longitudinal growth (Mackie et al., 2008).
Within cartilage, chondrocytes are responsible for the
secretion of extracellular matrix (ECM) molecules, such as
proteoglycans, mainly Aggrecan, which form the extrafibrillar
matrix and collagens, mainly Collagen II, which form the fibrillar
matrix.
It is well known that damaged cartilage has poor intrinsic
regenerative capacity, due to the peculiar nature of the tissue
itself, lacking blood and lymphatic networks; consequently
chondrocytes have a limited availability of oxygen and nutrients
(Lafont, 2010; Madry et al., 2010).
The current clinical approaches aimed to repair and
regenerate a damaged articular cartilage include osteochondral
transplantation (Chow et al., 2004; Coons and Barber, 2005),
MSC stimulation based therapies like microfracture surgery
and, more recently, cell-based strategies such as autologous
chondrocytes (O’Driscoll, 1998; Richardson et al., 1999) and
MSCs implantation (Wakitani et al., 2011; Jo et al., 2014). The
use of differentiated chondrocytes transplantation has shortly
shown its limitations in the functional restoration of chondral
tissue due to the scarcity of donor sites (cells can be collected
only from articular and nasal cartilage) and to the instability of
cells grown in monolayer culture, as chondrocytes dedifferentiate
to a fibroblastic phenotype (Benya and Shaffer, 1982). On the
other hand, MSC implantation seemed to be the most reliable
approach for cartilage regeneration, seen recent clinical studies,
utilizing the intra-articular injection of MSCs for cartilage repair,
which reported a significant reduction of pain, the restoration
of tissue functionality and the regeneration of hyaline-like
cartilage (Wakitani et al., 2011; Jo et al., 2014). Intra-articular
MSCs implantation is usually performed using biocompatible
hydrogels in order to promote local cells attachment resembling
Abbreviations: MSCs, Mesenchymal Stem Cells; ECM, Extracellular Matrix;
hADSCs, Human Adipose Derived Stem Cells; DAPI, 4′,6-diamidino-2-
phenylindole; GAG: Glycosaminoglycans; H&E: Haematoxylin and Eosin.
the ECM microenvironment and to avoid unwanted cell loss
(Spiller et al., 2011). To enhance the performance of these
materials in achieving a complete restoration of functional
cartilage, a number of critical issues have to be addressed.
An optimal balance between physical (density, porosity,
elasticity, flexibility, ability to sustain, and transmit pressure
loads) and biological properties (biocompatibility, absence
of cytotoxicity and antigenicity, capable of promoting cell
attachment, proliferation, and differentiation) of the filling
material is mandatory for an adequate clinical translation and
additional issues regarding isolation and manipulation of cells
still need to be addressed (Minguell et al., 2013; Hoch and Leach,
2014). The identification of companion chemical inducers and
modulators that may strengthen the innate properties of the
biomaterial to support and guide chondrogenesis may also be
extremely beneficial and lead to the development of complete
and effective therapeutic strategies in orthopedic regenerative
medicine.
For these reasons the development of new technological
solutions able to promote the restoration of chondral tissue
structure and its functional properties represent attracting
alternatives for cartilage therapy.
Recently, our laboratory showed the potential of a novel
collagen/hydroxyapatite biomimetic scaffold in inducing new
bone formation both in vitro, in combination with human
MSCs (Calabrese et al., 2016a) and in vivo, after implantation
of the empty scaffold into the dorsum of mice (Calabrese
et al., 2016b). These studies demonstrated that collagen-
hydroxyapatite scaffold was able to commit human MSCs
toward osteogenic differentiation already in vitro (Calabrese
et al., 2016a); in addition, the same type of scaffold, in vivo,
was able to recruit host MSCs and to induce these cells to
differentiate toward an osteocyte-like phenotype and, hence, to
stimulate the formation of new bone tissue (Calabrese et al.,
2016b).
In the same way, in this work, we have evaluated, in vitro,
the chondrogenic differentiation potential of a new 3D scaffold
mainly composed by equine type I Collagen, in combination
with human adipose-derived MSCs which possess a higher
chondrogenic potential compared to MSCs isolated from other
tissues (Calabrese et al., 2015), either in absence or presence of
chondrogenic inducing factors. The microstructural properties
of the proposed scaffold composition resembles the chondral
tissue in term of density and elasticity but its Collagen I based
composition allow to couple its biocompatibility and biomimetic
properties to a simple and inexpensive productive process
(Deponti et al., 2014).
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MATERIALS AND METHODS
Scaffold Structure
Cylindrical scaffolds were manufactured by Fin-Ceramica Faenza
SpA (Faenza–Ravenna, Italy) starting from equine type I collagen
gel (1 wt%) supplied in aqueous acetic buffer solution (pH =
3.5) (Opocrin SpA, Modena, Italy). The collagen gel was gently
diluted in highly purifiedwater and precipitated in fibers by drop-
wise addition of 0.1 M NaOH solution up to the isoelectric point
(pH = 5.5). In order to stabilize the scaffold whole structure, the
molecular links between fibers was chemically optimized by using
1,4-butanediol diglycidyl ether (BDDGE) as crosslinking agent.
The crosslinking reaction was achieved by 48 h-long immersion
of the agglomerated fibers at 37◦C in NaHCO3/Na2CO3 (Sigma
Aldrich and Merck Millipore) buffered aqueous solution with a
BDDGE solution ratio equals to 1 wt%.
The agglomerated fibers were then freeze-dried with a
controlled freezing and heating ramp from 25◦C to −35◦C
and from −35◦C to 25◦C achieving a porous 3D structure.
The process was carried out over a period of 25 h under
vacuum conditions (P = 0.29 mbar). Scaffold was then reshaped
in cylinders of required diameters and height for physical
characterization (Ø= 10–18 mm, h= 4 mm), in vitro and in vivo
analysis (Ø= 8mm, h= 5mm). Scaffolds were gamma-sterilized
at 25 kGy.
Scaffolds were characterized in porosity, swelling behavior and
material density.
The morphological and microstructural analysis was executed
by Scanning Electron Microscopy (SEM) performed on a SEM-
LEO 438 VP (Carl Zeiss AG, Oberkochen, Germany). The
samples were sputter-coated with gold prior to examination. 3
SEM micrographs were analyzed by image J software. The mean
pore diameter was calculated as average of the major and minor
axes of the ellipse representing pores cross-section. A total of 327
pores were analyzed obtaining a mean value of 67± 31 micron.
The swelling capacity of the material was evaluated on 20
cylindrical scaffolds (ø = 10 mm, h = 4 mm) of cartilage-like
composition. Dry scaffolds were soaked at room temperature
in PBS (Alchimia) until stabilization of scaffold dimension was
reached. The swelling was then determined as percent increase in
both dimensions and evaluating the weight increase as described
by Ma et al. (2003). Outlier values (Huber test) were deleted from
the data analysis.
The density and porosity of the collagen-based scaffold were
evaluated with a glass pycnometer full of highly purified water on
20 scaffolds (d = 18 mm; h= 4 mm) (She et al., 2007).
The porosity of the scaffolds was then evaluated using the
average value of the densities obtained and the geometric volume
of the scaffolds.
ϕ = 1− (M1/Vg)/ρr (1)
where:
M1=Mass of collagen scaffold
Vg= Geometric Volume of the scaffold (cylinder)
ρr=mean value density
Samples have been tested in triplicate.
Isolation, Expansion and Characterization
of Human Adipose Derived Stem Cells
Human adipose derived stem cells (hADSCs) were derived from
adipose tissue biopsies/lipoaspirates supplied by Mediterranean
Institute of Oncology (IOM) (Viagrande, Italy) under an
approved Institutional Review Board protocol (project ID code:
829_1 of 8 February 2013, IOM Institutional Review Board) and
after informed consent. Isolation from adipose tissue, expansion
and characterization by flow cytometry analysis using several
MSCs surface markers of hADSCs was performed as previously
reported (Calabrese et al., 2015, 2016a; Vicari et al., 2016). In
addition, cells were characterized also by immunocytochemistry
analysis using several positive (CD105, CD90, CD73, CD271) and
negative (CD45, CD34, CD31, and GlycoforinA) MSCs surface
markers.
Immunocytochemistry was performed on cells seeded in 8-
well BD Falcon culture slides at a density of 5000 cells per cm2
inMSC-GM (Lonza, Basel, Switzerland). The primary incubation
was performed, overnight at 4◦C, with the following anti-human
antibodies: mouse CD105 (1:50, Novus Biologicals, Littleton,
CO, USA), mouse CD90 (1:50, Santa Cruz Biotechnology,
Dallas, TX, USA), mouse CD73 (1:25, Novus Biologicals),
mouse CD271 (1:100, Santa Cruz Biotechnology), rabbit CD45
(1:100, Epitomics, Burlingame, CA, USA), rabbit CD34 (1:100,
Epitomics), mouse CD31 (1:100, Santa Cruz Biotechnology), and
goat polyclonal anti Glycoforin A (1:100, Novus Biologicals).
After washing, slides were incubated with the appropriate
secondary AlexaFluor 568 and 488 antibodies (Life Technologies
Italia, Monza, Italy) at the dilution of 1:2000 for 1 h at RT. Nuclei
were counterstained with DAPI (4’,6-diamidino-2-phenylindole,
1:10,000). Finally, slides were mounted in fluorescent mounting
medium Permafluor (Thermo Scientific, Waltham, MA, USA)
and digital images were acquired using a Leica DMI4000B
fluorescence microscope (Leica, Wetzlar, Germany). Control
of immunostaining specificity was performed by omitting the
primary antibody.
For flow cytometry analysis, cells were detached with 0.05%
trypsin/EDTA and washed in PBS. 1 × 104 cells/tube were
stained with the following antibodies: CD45 FITC (Clone J.33),
CD34 PE (Clone 581), Glycophorin A PE (Clone 11E4B-7-6),
CD73 PE (Clone 581), CD90 FITC (Clone F15.42.1.5), CD105
PE (Clone 1G2), CD31PE (Clone 1F11), CD271 FITC (Clone
ME20.4-1.H4) and corresponding isotypic controls according
to manufacturer indications. All antibodies were purchased
from Beckman Coulter (Milano,Italy), except CD271 that was
provided by Miltenyi Biotec (Bologna, Italy). All tubes were
incubated in the dark for 20 min at room temperature. Cells were
then washed with PBS and finally analyzed by flow cytometry
using an FC-500 five-color flow cytometer (Beckman Coulter,
Pasadena, CA, USA). For each tube, 1000 events were acquired.
CXP Analysis software (Beckman Coulter, Inc.) was used for data
analysis.
hADSC Chondrogenic Differentiation
hADSC chondrogenic differentiation was achieved as previously
described (Calabrese et al., 2015). Briefly, 2.5 × 105 cells
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were centrifuged to form a three-dimensional aggregate and
resuspended in complete chondrogenic medium containing
differentiation basal medium (Chondrogenic Basal Medium,
Lonza) supplemented with chondrogenic differentiation
inducing factors (hMSC Chondrogenic SingleQuots containing
Dexamethasone, Ascorbate, ITS+supplement, GA-1000 Sodium
Pyruvate, Proline and L-Glutamine, Lonza) and TGF-β3 (Lonza).
Pellets were incubated at 37◦C in a humidified atmosphere of
5% CO2. The growth medium was replaced every 2–3 days. The
chondrogenic differentiation was completed on day 28 after
induction. Pellets were fixed in formalin at three different time
points along differentiation (1, 2, and 4 weeks). Subsequently,
pellets were paraffin embedded and cut into 3 µm-thick sections
for immunohistological processing.
Immunohistochemical Analysis of Pellets
After deparaffinization and rehydration, sections were
permeabilized with 0.4% Triton-X100, blocked with 4%
BSA and then incubated overnight at 4◦C with the following
rabbit polyclonal primary antibodies: anti-Aggrecan (1:150),
anti-Matrilin-1 (1:200), anti-Sox9 (1:200), anti-type II Collagen
II (1:200), all purchased from LSBio (Seattle, WA, USA). The
following day, sections were incubated for 1 h at RT with the
Alexa Fluor anti-rabbit 568 secondary antibodies (1:2000, Life
Technologies). Then slides were counterstained with DAPI
(1:10,000) and mounted with Permafluor (Thermo Scientific).
Control of immunostaining specificity was performed by
omitting the primary antibody.
hADSC Chondrogenic Differentiation on
Scaffolds
hADSC chondrogenic differentiation on scaffolds was performed
as previously described (Calabrese et al., 2016a). Briefly, 2 × 106
hADSCs at passage 3 were slowly drip seeded onto the scaffold
and incubated in 24-well culture plates for 4 h at 37◦C. ADSC-
GM medium (2 ml) (Lonza, Basel, Switzerland) was added and
24 h later (day 0) the medium was replaced with chondrogenic or
expansion medium. Both media were completely replaced twice
a week. Each scaffold was analyzed on week 1, 2, 4, and 8 after
chondrogenic induction.
Histological and Immunohistochemical
Analysis on hADSCs-Scaffold
Scaffolds seeded with hADSC were fixed in 4% PFA at the
different time points analyzed (1, 2, 4, and 8 weeks), dehydrated,
embedded in paraffin and cut into 3 µm-thick sections. Sections
were mounted on slides and processed for immunohistochemical
staining as above reported, using the same rabbit polyclonal
primary antibodies: anti-Matrilin 1 (1:200, LSBio), anti-Aggrecan
(1:150, LSBio), anti-Sox 9 (1:200, LSBio) and anti-Collagen II
(1:200, LSBio). The following day, sections were incubated for 1 h
at RT with the Alexa Fluor anti-rabbit 568 secondary antibodies
(1:2000, Life Technologies Italia, Monza, Italy). Then slides
were counterstained with DAPI and mounted with Permafluor.
Control of immunostaining specificity was performed by
omitting the primary antibody. Alternate sections were also
labeled with Haematoxylin and Eosin (H&E) and with Alcian
Blue staining (Panreac, Castellar del Valles, Barcellona, Spain).
For the staining an Alcian Blue solution was prepared according
to manufactured protocol. Slides were first deparaffinised in
xylene and re-hydrated through passages in alcoholic solutions
and, then, stained in Alcian Blue solution for 30 min. After
incubation the staining solution was removed and the culture
slides washed to get rid of excessive color. Slides were mounted
and examined under light microscope.
Statistical Analysis
Cell count analysis has been performed using Fiji image
recognition software.
Data were analyzed as percentage of positive cells on total
number of DAPI stained cells. Differences between experimental
groups in histological data were evaluated by using two-way
ANOVA for culture condition (scaffold in expansion medium,
scaffold in chondrogenic medium o pellet differentiation) and
timepoint (1, 2, and 4 weeks) for each of the assessed molecular
endpoint (Sox9, Matrilin 1, Collagen II, and Aggrecan) followed
by Tukey’s HSD post-hoc test. For all experiments, a P < 0.05 was
considered significant. All analyses were performed by means of
Systat (Systat Software, USA).
RESULTS
Scaffold Fabrication and Characterization
The morphological and microstructural analyses of scaffolds
were performed by SEM. The scaffolds images displayed porosity
distribution from 16 to 180 µm, with larger channel (excluded
from the analysis).
SEM images of the cartilage layer are displayed in Figure 1
with different magnification, 30x (Figure 1A), 50x (Figure 1B),
and 150x (Figure 1C).
The cartilage-like layer shows a high level of porosity with
three-dimensional interconnected pores without any preferential
alignment of the collagen fibers. This kind of structures can help
the cells function and guide it during their proliferation.
A qualitative analysis of the pores distribution has been
performed, and it revealed a higher pores frequency, about the
65%, from 40 to 100 µm (Figure 1D).
Change of material structure was evaluated by swelling test.
Each scaffold was weighed before and after the use of PBS
solution to soak the scaffold. Swelling test clearly demonstrated
that scaffolds are highly hydrophilic reaching the steady state
in less than 1 min. The amount of PBS absorbed has been
measured to evaluate the collagen scaffold ability to preserve
liquid attributed to the maintenance of the three-dimensional
structure. The absorption capability of the collagen scaffold
resulted 2086± 238%.
Both diameter and thickness of the scaffold significantly
increased after swelling (Figure 1E). The change in thickness (27
± 9%) was much higher than in diameter (6± 1%).
The porosity of the cartilage in the biomaterial is crucial
to assure the cell colonization through the whole scaffold.
This parameter is related to the density of the biomaterial
forming the scaffolds. The importance of the cell colonization
directly influences scaffolds biocompatibility and cell adaptation
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FIGURE 1 | SEM images of collagen scaffold at (A) 30x, (B) 50x, and (C) 150x magnifications. (D) Graphical representation of pore size (µm) frequency
throughout the scaffold. (E) Graphical representation of collagen scaffold swelling behavior relative to the modification of diameter and thickness after soaking in PBS
solution. Blue columns, dry samples before soaking; red columns, wet samples after soaking.
toward the scaffold. The evaluation of the scaffolds porosity was
determined using the medium of the densities obtained through
a glass pycnometer and the geometric volume of the cylindrical
shaped scaffolds. Applying the reported formula the density
found is 0.89± 0.22 g/cm3 giving a porosity of 95.79± 0.29%.
hADSCs Phenotypic Characterization
All the experiments have been conducted with MSCs isolated
from adipose tissue, and characterized by immunocytochemistry
(Figure 2A) and flow cytometry (Figure 2B) analysis using
several MSCs surface markers. Three different hADSC lines were
used to study the expression of typically positive (CD73, CD90,
CD105, CD271) and negative (CD31, CD34, CD45, glycoforin
A) surface markers of stemness. In both analysis, all cell lines
presented a strong positivity for CD73, CD90, CD105, and
CD271, while no signal was detected for CD31, CD34, CD45, and
glycoforin A (Figure 2).
Biocompatibility and Chondrogenic
Potential of the Collagen Scaffold vs.
hADSCs
Firstly, we wanted to evaluate the in vitro biological performance
of a novel 3D porous scaffold, in terms of biocompatibility and
ability to support hADSCs to differentiate toward a chondrocyte
phenotype.
We have already demonstrated that hADSCs and bone-
like scaffold have a high biocompatibility (Calabrese et al.,
2016a). In this work, we found the same high biocompatibility
of hADSCs with the collagen-based scaffold, as shown by
haematoxylin and eosin (H&E) staining (Figure 3) that reveals
the ability of cells to penetrate, adhere and proliferate into
the scaffold. In particular, hADSCs loaded onto the scaffold
were confined only on the surface during the first 2 weeks
(Figures 3A–D), then, cells started to invade also the inner
part of the scaffold, penetrating deeply inside (Figures 3E–H).
This was observed in both experimental culture conditions: with
expansion medium (Figures 3A,C,E,G) and with chondrogenic
medium (Figures 3B,D,F,H), although a significant difference
between the two experimental conditions was noted, in terms of
cellularity and extracellular matrix quality. In fact H&E staining
revealed not only the biocompatibility but also the differential
proliferative and differentiation potential of the scaffold in the
two different experimental conditions. Specifically, in expansion
medium, at 1 week, cells are few and still confined on the
surface of the scaffold, over the time, from 1 to 4 weeks,
cells proliferate and migrate inside the scaffold, the scaffold
results wrapped by a layer of spindled to stellate fibroblast-like
cells that progressively invade the innermost part of material
(Figures 3A,C,E,G). Anyway, at 4 weeks cells begin to appear
suffering (Figure 3E), and, surprisingly, cellular necrosis and
regressive phenomena occurred at 8 weeks (Figure 3G), as better
shown in the squared image at higher magnification (Figure 3G
square).
On the other hand, in presence of chondrogenic inducing
factors (chondro medium) the increase in cellularity from first
to eighth week is much more evident if compared with the
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FIGURE 2 | Immunofluorescent (A) and flow cytometry analyses (B) of negative (CD31, CD34, CD45, and GlycoforinA) and positive (CD73, CD90, CD105, and
CD271) mesenchymal stem cells surface markers (red and green stains). Nuclei are labeled in blue. Power magnification: 20x. Scale bar: 100 µm.
same samples without inducing factors (expansion medium).
In particular, starting from the second week (Figure 3D) it
is also quite evident that the extracellular matrix assumes a
chondromyxoid-like feature which progressively increases up
to 8 weeks (Figures 3F,H). In fact, MSCs start to go toward
condensation and differentiate in chondrocytes. The different
nature of the cells is better highlighted in the images at higher
magnification (Figures 3I–L) showing spindled and stellate cells
during the first 2 weeks (Figures 3I,J). At 4 weeks the presence of
pericellular lacunae (arrows) resembling chondrocytes, become
quite clear (Figure 3K). At 8 weeks the chondromyxoid-like
nature of the extracellular matrix, typical of cartilage tissue,
with bigger and more numerous pericellular lacunae, is strongly
evident (Figure 3L).
These observations were strongly confirmed by the Alcian
Blue staining (Figure 4) that highlighted a striking difference
between the samples in expansion medium (Figures 4A,C,E,G)
and the samples in chondrogenic medium (Figures 4B,D,F,H),
in terms of extracellular matrix nature. In expansion medium
the blue staining did not reveal any chondromyxoid-like nature,
whereas the presence of bioactive factors in the culture medium
lead to the deposition of an extracellular matrix, starting to
be visible already at 1 week, in which spindled and stellate
mesenchymal cells are still present (Figures 4B,I). From the
second week the amount of extracellular matrix deposition is
bigger (Figure 4D) and become more and more consistent at
4 (Figure 4F) and 8 weeks (Figure 4H), where chondrocyte-
like mesenchymal cells (Figures 4J,K) are embedded in a
chondromyxoid-like matrix, presenting the typical cartilage
pericellular lacunae, strongly evident in the higher magnification
Figure 4L. The intense Alcian Blue staining confirms the
cartilage-like nature of the neo-formed tissue.
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FIGURE 3 | (A) Haematoxylin-Eosin staining of hADSC cultured on scaffolds either in absence (expansion medium) or presence (chondro medium) of chondrogenic
inducing factors in culture media, after 1 (A,B), 2 (C,D), 4 (E,F), and 8 (G,H) weeks of growth in culture, magnification 20x. (I–L) higher power magnifications of the
squared area, respectively, in (B,D,F,H). The arrows in (K) indicate the presence of pericellular lacunae resembling chondrocytes.
hADSCs Chondrogenic Differentiation
Performance of Scaffold and Conditioning
Medium
In order to assess the chondro-inductive character of the
scaffold in combination with the bioactive factors, we decided
to compare the performance of the reference protocol defined
by the inductive media manufacturer with the ones achievable
by culturing of hADSCs on the collagen based 3D scaffold
in both absence (expansion medium) or presence (chondro
medium) of chondrogenic factors. At this aim we performed
immunohistochemical analysis using markers typical of
chondrogenic differentiation, including Sox9, type-II Collagen,
Aggrecan and Matrilin-1.
Sox9 is a transcription factors that controls the expression
of type II Collagen and Aggrecan and has a crucial role in
chondrogenesis (Bi et al., 1999). The immunohistochemical
analysis of Sox9 shows only few labeled nuclei during the first
week in all experimental conditions (Figures 5A,D,G), at the
second weeks a more evident fluorescent signals is present only
in the pellet (Figures 5B,E,H), at 4 weeks a further increase is
clearly visible in the pellet (Figure 5C), while the scaffold samples
show a slight augment of Sox9 marked nuclei in both conditions,
although in chondro medium (Figure 5F) such increase results
higher compared to the expansion medium (Figure 5I).
In accordance with Sox9, Type-II Collagen
immunohistochemical analysis shows a very weak
staining during the first two weeks in all three conditions
(Figures 5J,K,M,N,P,Q), although slightly more evident in the
pellet (Figures 5J,K), whereas, starting from 4 weeks a more
robust and extended signal becomes visible, although it results
significantly higher in the pellet and in the scaffold samples in
presence of inducing factors (Figures 5L,O), compared to the
scaffold without bioactive factors (Figure 5R).
Aggrecan immunohistochemical analysis shows a protein
expression pattern comparable to that of Type-II Collagen.
Specifically, immunohistochemistry for Aggrecan reveals almost
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FIGURE 4 | Alcian Blue staining of hADSC cultured on scaffolds either in absence (expansion medium) or presence (chondro medium) of
chondrogenic inducing factors in culture media, after 1 (A,B) , 2 (C,D), 4 (E,F), and 8 (G,H) weeks of growth in culture, magnification 20x. (I–L) higher power
magnifications of the squared area shown, respectively, in (B,D,F,H). The arrows in (K) indicate the presence of pericellular lacunae resembling chondrocytes.
no signal during the first 2 weeks in both experimental conditions
of the scaffold samples (Figures 6D,E,G,H), while in the pellet
is already present a visible fluorescence at 1 week (Figure 6A)
that becomes a little higher a 2 weeks (Figure 6B); at 4 weeks
the pellet fluorescent staining is very strong (Figure 6C). At 4
weeks in scaffold, a modest fluorescent labeling is present in
expansion medium (Figure 6I), while a quite stronger staining
appears in chondrogenic medium (Figure 6F). Aggrecan is the
principal proteoglycan (GAG) present in the ECM and forms,
along with type-II collagen, the main structural element of the
cartilage. As far as type-II Collagen, Aggrecan at 4 weeks presents
a filamentous appearance (Figures 6C,F,I).
Matrilin-1 results very weakly expressed during the first
4 weeks of scaffold cultures in absence of differentiation
inducing factors (Figures 6P–R). Conversely, in presence of
chondrogenic inducing factors, already at 1 week a modest signal
was visible (Figures 6L,O) both in pellet and scaffold samples
(Figures 6J,M). Over time, the intensity and the extent of the
fluorescent staining gradually increases until to be very strong at
4 weeks (Figures 6K,L,N,O), even if always a little higher in the
pellet.
Results indicate that statistically significant differences in
markers expression exist between all the differentiation methods
assessed (p < 0.001), as graphically presented in Figures 5X, 6X.
DISCUSSION
During life, hyaline cartilage of articular joints is constantly
exposed to several static and dynamic compression loads due
to both normal activities, such as stair climbing (Hodge et al.,
1986), and traumatic events. Such continuous stresses lead to
a progressive degeneration of the cartilage with consequent
pain, swelling, loss of function and, finally, osteoarthritis (or
degenerative joint disease) that represents the most common
musculoskeletal disorder (Jackson et al., 2001).
Still, cartilage healing remains a challenge mainly because
of its avascular nature. Several approaches aimed to restore
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FIGURE 5 | Immunofluorescent analysis of representative chondrogenic markers: (A–I) Sox9, (J–R) type II Collagen, performed on hADSCs and hADSCs
cultured on scaffolds either in expansion (G–I,P–R) or in chondrogenic (A–F,J–O) medium, at different time points (1, 2, and 4 weeks), magnification 20x. (X) Average
cellular positivity for chondrogenic markers in both expansion (dark bars) and chondrogenic medium (dark and medium bars). Percentage of Sox9 and Collagen II (X)
are calculated on the total number of DAPI stained cells in the investigated fields. Two-way ANOVA p values are reported. Symbols above bars indicate statistically
significant differences (p < 0.05) in the Tukey HSD post-hoc tests: 1 indicates differences with the 1 week group (same medium), 2 indicates differences with the 2
weeks group (same medium), 3 indicates differences with the 4 weeks group (same medium), 4 indicates differences with the 8 weeks group (same medium), *
indicates differences with scaffold expansion medium group (same time-points), # indicates differences with scaffold chondrogenic medium group (same timepoints)
and % indicates differences with pellet group (same timepoints). Average cellular positivity for chondrogenic markers at 2 (dark bars) and 4 weeks (light bars). Three
independently isolated hADSC samples have been used for each time-point.
injured cartilage, have been pursued by researchers and
clinicians. Among these, cell-based strategies have provided
some encouraging clinical results (O’Driscoll, 1998; Richardson
et al., 1999; Wakitani et al., 2011; Jo et al., 2014), although, the
major drawback of such approach is the failure in generating a
three-dimensional tissue having characteristics similar to native
cartilage concerning quality and stability (Vinatier et al., 2009a).
Newer tissue engineering strategies are focusing in developing
new chondro-inductive biomaterials capable of inducing a
complete healing of cartilage lesions in combination with
chondrogenic bioactive growth factors.
While various studies have shown the capability of MSCs
derived from different tissues to generate cartilage (Nakahara
et al., 1990; Arufe et al., 2010; Oldershaw, 2012), bone marrow
and adipose tissue are considered the most attractive sources
for therapeutic use of MSCs in cartilage repair and regeneration
(Somoza et al., 2014). However, bone marrow-derived MSCs
have an intrinsic endochondral ossification potential, definitely
higher than that of ADSCs (Mehlhorn et al., 2006; Diekman et al.,
2010), leading to the development of a hypertrophic chondrocyte
phenotype (Johnstone et al., 1998; Scotti et al., 2010), which is not
appropriate for articular cartilage repair.
Frontiers in Physiology | www.frontiersin.org 9 February 2017 | Volume 8 | Article 50
Calabrese et al. Chondrogenic Differentiation on Collagen Scaffold
FIGURE 6 | Immunofluorescent analysis of representative chondrogenic markers: (A–I) Aggrecan, (J–R) Matrilin, performed on hADSCs and hADSCs
cultured on scaffolds either in expansion (G–I,P–R) or in chondrogenic (A–F,J–O) medium, at different time points (1, 2, and 4 weeks), magnification 20x. (X) Average
cellular positivity for chondrogenic markers in both expansion (dark bars) and chondrogenic medium (dark and medium bars). Percentage of Aggrecan and Matrilin (X)
are calculated on the total number of DAPI stained cells in the investigated fields. Two-way ANOVA p values are reported. Symbols above bars indicate statistically
significant differences (p < 0.05) in the Tukey HSD post-hoc tests: 1 indicates differences with the 1 week group (same medium), 2 indicates differences with the 2
weeks group (same medium), 3 indicates differences with the 4 weeks group (same medium), 4 indicates differences with the 8 weeks group (same medium), *
indicates differences with scaffold expansion medium group (same time-points), # indicates differences with scaffold chondrogenic medium group (same timepoints)
and % indicates differences with pellet group (same timepoints). Average cellular positivity for chondrogenic markers at 2 (dark bars) and 4 weeks (light bars). Three
independently isolated hADSC samples have been used for each time-point.
Recently, it has been reported that MSCs expressing CD105,
CD29 (Rada et al., 2011; Fan et al., 2016), as well as CD271
(Calabrese et al., 2015) revealed a greater chondrogenic potential
compared to other MSC subpopulations, including those derived
from bone marrow (Calabrese et al., 2015). Moreover, CD271-
positive MSCs exhibited the highest level of type II collagen
and Aggrecan, after chondrogenic induction (Nakahara et al.,
1990).
Here we propose a novel combination of a collagen based
3D scaffold, CD271-positive MSCs, isolated from adipose tissue
(hADSC) and chondrogenic differentiation inducing soluble
factors as a potential tool for cartilage regeneration.
Several types of scaffold, both of synthetic and natural origin,
have been already reported in literature as suitable tool for
cartilage engineering (Vinatier et al., 2007, 2009b; Zeugolis et al.,
2008; Eglin et al., 2010; Solorio et al., 2013; Dahlin et al., 2014;
Tsai et al., 2015; He et al., 2016; Hung et al., 2016; Raftery
et al., 2016). A scaffold is a three-dimensional structure capable
to support cell colonization, proliferation, and differentiation
of appropriate cells. Stimuli mimicking the in vivo cartilage
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environment are needed for pushing cells to differentiate into
mature chondrocytes.
We have recently demonstrated that a collagen-
hydroxyapatite scaffold is able to commit human MSCs toward
osteogenic differentiation, in vitro (Calabrese et al., 2016a) and
in vivo (Calabrese et al., 2016b). Accordingly, in this study, we
have evaluated the ability of a novel scaffold composition, to
induce hADSCs to differentiate into chondrocytes, in vitro and
compared the differentiation potential of hADSCs seeded on
scaffold and in cellular pellet.
Chondrogenic differentiation of condensed cellular pellet is
defined as a standard protocol for the in vitro commitment of
MSC toward chondrogenic lineage using the above specified
conditioning medium (see Materials and Methods section).
The chondrogenic potential of this procedure has been used
as benchmark to evaluate differentiation potential of hADSC
cultured in collagen based scaffold both in presence and absence
of the conditioning medium. The chondrogenic differentiation
was evaluated by immunofluorescent analysis of specific cartilage
markers. In particular, (i) Sox9, a transcription factor playing
a crucial role in chondrogenesis, which controls the expression
of type II Collagen and Aggrecan; (ii) type-II Collagen, that
is the core of articular and hyaline cartilage, it forms fibrils
and represent more than 50% of all protein and about the
unique type of collagen in articular cartilage; (iii) Aggrecan,
that forms, together with type-II Collagen, a major structural
component of cartilage, and represents the major proteoglycan in
the articular cartilage; (iv) Matrilin-1, which is a protein involved
in the formation of filamentous networks in the cartilage ECM
interacting with both type-II Collagen and Aggrecan in the ECM.
All the markers used have shown their highest expression at the
last time point studied of hADSCs chondrogenic differentiation
(4 weeks). Results indicate that statistically significant differences
in markers expression exist between all the differentiation
methods assessed (p < 0.001). In particular is clearly evident
that when hADSC are cultured on scaffold the percentage of
SOX9 and Matrilin positive cells is significantly higher after 1
week of differentiation both in presence or absence of soluble
factors. When conditioning factor are not present the augmented
expression of chondral markers observed in scaffold cultured
cells decrease with time, with cells differentiated in pellet showing
a comparable (Collagen II and Matrilin-1) or significantly
augmented (SOX9 and Matrilin-1) protein expression. In almost
every time point investigated, cells cultured on 3D scaffold in
presence of conditioning medium exhibit a significantly higher
expression of all the chondral markers observed suggesting
that hADSC are committed faster than in the other culturing
conditions.
In our model, the scaffold is composed principally by type-
I Collagen. Importantly, the scaffold biomaterial has shown a
high biocompatibility, defined as the ability to support host cell
proliferation and differentiation and to promote the formation of
the extracellular matrix on scaffold surface and pores.
The data obtained from our in vitro studies have shown
that the scaffold, per se, seemed to be sufficient to induce
differentiation of hADSCs layered on top into early chondrocyte
precursors. This has been demonstrated by the appearance of
lineage specific markers, although in less extent and in later time
compared to the samples grown in chondrogenic medium. On
the other hand, H&E and Alcian Blue stainings have shown not
only the absence of a chondromyxoid-like ECM in expansion
medium, but also that at 4 weeks cells became suffering and
underwent to cellular necrosis and regressive phenomena. Hence,
our hypothesis is that, in absence of bioactive factors, the
scaffold can promote an initial hADSCs differentiation into early
chondrocyte precursors, which begin to express chondrogenic
markers; but, afterwards, the scaffold alone is not able to drive
a complete chondrogenic differentiation, leading cells to death.
On the other hand, the addition of chondro-inductive factors
to the culture medium (chondro medium samples) significantly
speeded up the differentiation process, as suggested by the
stronger and earlier chondrogenic marker expression. Moreover,
the H&E and Alcian blue stainings revealed not only an increase
in cellularity but also the production of an ECM having a
chondromyxoid-like nature. Moreover, cells embedded in the
ECM are surrounded by pericellular lacunae, strongly resembling
chondrocytes of mature cartilage.
In conclusion, the data presented in this work demonstrated
that hADSCs could represent a source of election of MSCs
to use in cartilage tissue engineering applications, due to
their easy harvest and chondrogenic potential (Calabrese et al.,
2015). Moreover, the collagen scaffold used showed a high
biocompatibility with hADSCs. The in vitro data showed that
the biomaterial composing the scaffold possesses the intrinsic
property of promoting an initial chondrogenic differentiation of
hADSCs, even if not sufficient to lead to the complete hADSC
differentiation into chondrocytes. However, the combination of
scaffold with bioactive factors strongly accelerates the process
leading to the formation of a new-formed tissue strongly
resembling cartilage.
Hence, the present work suggests that the combination
of hADSCs, collagen biomaterial and chondrogenic inducing
factors, could represent a promising tool to be used in
tissue engineering for restoration and regeneration of damaged
articular cartilage.
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